Table 1:
Comparison of baseline characteristics in intervention and placebo groups
| Baseline characteristics | Group |
P | |
|---|---|---|---|
| Vitamin D | Placebo | ||
| Demographic factors | |||
| Sex (male) | 20 (90.91%) | 20 (90.91%) | |
| Age (years) | 58.09±9.91 | 57.59±9.62 | 0.866 |
| Measurements factors | |||
| BMI | 27.73±3.08 | 26.79±2.86 | 0.299 |
| Waist (cm) | 100.57±6.76 | 98.66±8.01 | 0.398 |
| Laboratory factors | |||
| TC (mg/dl) | 140.67±34.92 | 152.67±44.57 | 0.337 |
| TG (mg/dl) | 167.188±71.84 | 167.667±95.89 | 0.393 |
| HDL (mg/dl) | 37.14±9.12 | 36.14±10.36 | 0.742 |
| LDL (mg/dl) | 71.67±19.81 | 80.86±28.89 | 0.236 |
| 25(OH) Vitamin D (ng/ml) | 17.41±6.89 | 18.70±6.97 | 0.545 |
| FBS (mg/dl) | 101.81±18.24 | 111.67±30.82 | 0.214 |
| AST | 25.94±13.31 | 22.19±6.61 | 0.861 |
| ALT | 32.19±14.93 | 39.14±25.58 | 0.288 |
| CRP (Mean±SD) | 2.36±2.99 | 2.32±2.47 | 0.781 |